|
PYROXD1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.08260125495508E-11 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.40090000605642E-09 |
| Normal-vs-Stage2 |
4.114500E-02 |
| Normal-vs-Stage3 |
3.52019999816378E-08 |
| Normal-vs-Stage4 |
2.62301291797939E-12 |
| Stage1-vs-Stage2 |
2.423800E-01 |
| Stage1-vs-Stage3 |
4.310800E-01 |
| Stage1-vs-Stage4 |
3.670500E-02 |
| Stage2-vs-Stage3 |
1.305380E-01 |
| Stage2-vs-Stage4 |
3.241800E-02 |
| Stage3-vs-Stage4 |
3.719000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.17990017335057E-10 |
| Normal-vs-AfricanAmerican |
1.70563563273163E-12 |
| Normal-vs-Asian |
2.571800E-02 |
| Caucasian-vs-AfricanAmerican |
2.760000E-04 |
| Caucasian-vs-Asian |
9.235800E-01 |
| AfricanAmerican-vs-Asian |
9.822200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.72168962314845E-12 |
| Normal-vs-Female |
1.64018999999627E-05 |
| Male-vs-Female |
4.182100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.35989006114323E-12 |
| Normal-vs-Age(41-60Yrs) |
4.6600999947799E-08 |
| Normal-vs-Age(61-80Yrs) |
6.26860008345886E-10 |
| Normal-vs-Age(81-100Yrs) |
6.032100E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.623000E-04 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.600400E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.101730E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.005800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.852200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.578000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.040200E-03 |
| Normal-vs-Grade 2 |
1.011040E-04 |
| Normal-vs-Grade 3 |
2.47002418518605E-12 |
| Normal-vs-Grade 4 |
1.62947433324234E-12 |
| Grade 1-vs-Grade 2 |
4.383800E-01 |
| Grade 1-vs-Grade 3 |
5.016200E-01 |
| Grade 1-vs-Grade 4 |
4.922300E-02 |
| Grade 2-vs-Grade 3 |
5.476600E-03 |
| Grade 2-vs-Grade 4 |
2.78809999998408E-06 |
| Grade 3-vs-Grade 4 |
5.238600E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.630100E-02 |
| Normal-vs-ccB subtype |
1.6876500197327E-12 |
| ccA subtype-vs-ccB subtype |
1.25200000367087E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.31019999691529E-08 |
| Normal-vs-N1 |
1.361410E-04 |
| N0-vs-N1 |
3.877000E-01 |
|
|
